Light-emitting diode therapy in chemotherapy-induced mucositis

Lasers in Surgery and Medicine

Volumn 40, Issue 9, 2008, Pages 625-633

  Sacono, Nancy T ^a   Costa, Carlos A S ^a   Bagnato, Vanderlei S ^b   Abreu e Lima, Fabio C B ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Drug therapy; Fluorouracil; Hamsters; Neoplasms; Oral mucosa; Phototherapy

Indexed keywords

FLUOROURACIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CHEMOTHERAPY; CONTROLLED STUDY; DISEASE SEVERITY; HAMSTER; HISTOLOGY; LIGHT EMITTING DIODE; MALE; MUCOSA INFLAMMATION; MUSCLE ATROPHY; NONHUMAN; ORAL BIOPSY; PHOTOTHERAPY; PRIORITY JOURNAL;

ANIMALS; ANTINEOPLASTIC AGENTS; CHEEK; CRICETINAE; DISEASE MODELS, ANIMAL; FLUOROURACIL; MALE; MESOCRICETUS; PHOTOTHERAPY; STOMATITIS;

EID: 55449107710     PISSN: 01968092     EISSN: 10969101     Source Type: Journal    
DOI: 10.1002/lsm.20677     Document Type: Article

References (45)

1. Rubenstein EB, Peterson DE, Schubert M, Keefe D, McGuire D, Epstein J, Elting LS, Fox PC, Cooksley C, Sonis ST. Clinical practice guidelines for the prevention and treatment of cancer therapy-induced oral and gastrointestinal mucositis. Cancer 2004;100:2026-2046.
2. Spijkervet FKL, Sonis ST. New frontiers in the management of chemotherapy-induced mucositis. Curr Opin Oncol 1998;10(Suppl 1):S23-S27.
3. Epstein JB, Tsang AH, Warkentin D, Ship JA. The role of salivary function in modulating chemotherapy-induced oropharyngeal mucositis: A review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2002;94:39-44.
4. Parulekar W, Mackenzie R, Bjarnason G, Jordan RCK. Scoring oral mucositis. Oral Oncol 1998;34:63-71.
5. Epstein JB, Schubert MM. Oral mucositis in myelosuppressive cancer therapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1999;88:273-276.
6. Scully C, Sonis ST, Diz PD. Oral mucositis. Oral Dis 2006;12:229-241.
7. Worthington HV, Clarkson JE. Prevention of oral mucositis and oral candidiasis for patients with cancer treated with chemotherapy: Cochrane systematic review. J Dent Educ 2002;66:903-911.
8. Sonis ST. Mucositis as a biological process: A new hypothesis for the development of chemotherapy-induced stomatotoxicity. Oral Oncol Eur J Cancer 1998;34:39-43.
9. Sonis ST, Costa JW Jr, Evitts SM, Lindquist LE, Nicolson M. Effect of epidermal growth factor on ulcerative mucositis in hamsters that receive cancer chemotherapy. Oral Surg Oral Med Oral Pathol 1992;74:749-755.
10. Sonis ST, Muska A, O'Brien J, VanVugt A, Langer-Safer P, Keith J. Alteration in the frequency, severity and duration of chemotherapy-induced mucositis in hamsters by interleukin-11. Eur J Cancer B Oral Oncol 1995;31B:261-266.
11. Sonis ST, Van Vugt AG, McDonald J, Dotoli E, Schwertschlang U, Szklut P, et al. Mitigating effects of interleukin 11 on consecutive courses of 5-fluoruracil-induced ulcerative mucositis in hamsters. Cytokine 1997;9:605-612.
12. Hejna M, Köstler WJ, Raderer M, Steger GG, Brodowicz T, Scheithauer W. Decrease of duration and symptoms in chemotherapy-induced oral mucositis by topical GM-CSF: Results of a prospective randomized trial. Eur J Cancer 2001;37:1994-2002.
13. Spielberger R, Stiff O, Besinger W, Gentile T, Weisdorf D, Kewalramani T, et al. Palifermin for oral mucositis after intensive therapy for hematologic cancers. N Engl J Med 2004;351:2590-2598.
14. Duncan M, Grant G. Oral and intestinal mucositis - Causes and possible treatments. Aliment Pharmacol Ther 2003;18:853-874.
15. Stokman MA, Spijkerevet FKL, Boezen HM, Schouten JP, Roodenburg JLN, de Vries EGE. Preventive intervention possibilities in radiotherapy- and chemotherapy-induced oral mucositis: Results of meta-analyses. J Dent Res 2006;85:690-700.
16. Barasch A, Peterson DE, Tanzer JM, D'ambrosio JA, Nuki K, Schubert MM, et al. Helium-Neon laser effects on conditioning - Induced oral mucositis in bone marrow transplantation patients. Cancer 1995;76:2550-2556.
17. Cowen D, Tardieu C, Schubert M, Peterson D, Resbeut M, Faucher C, et al. Low energy helium-neon laser in the prevention of oral mucositis in patients undergoing bone marrow transplant: Results of a double blind randomized trial. Int J Radiat Oncol Biol Phys 1997;38:697-703.
18. Bensadoun RJ, Franquin JC, Ciais G, Darcourt V, Schubert MM, Viot M, et al. Low-energy He/Ne laser in the prevention of radiation-induced mucositis. A multicenter phase III randomized study in patients with head and neck Cancer Support Care Cancer. 1999;7:244-252.
19. Sandoval RL, Koga DH, Buloto LS, Sukuzi R, DIB LL. Management of chemo- and radiotherapy induced oral mucositis with low-energy laser: Initial results of A.C. Camargo hospital. J Appl Oral Sci 2003;11:337-341.
20. Wong SF, Wilder-Smith P. Pilot study of laser effects on oral mucositis in patients receiving chemotherapy. Cancer J 2002;8:247-254.
21. Nes AG, Posso MBS. Patients with moderate chemotherapy-induced mucositis: Pain therapy using low intensity lasers. Int Nurs Rev 2005;52:68-72.
22. Whelan HT, Buchmann EV, Dhokalia A, Kane MP, Whelan NT, Wong-Riley MT. Effect of NASA light-emitting diode irradiation on molecular changes for wound healing in diabetic mice. J Clin Laser Med Surg 2003;21:67-74.
23. Vinck EM, Cagnie BJ, Cornelissen MJ, Declercq HA, Cambier DC. Increased fibroblast proliferation induced by light emitting diode and low power laser irradiation. Lasers Med Sci 2003;18:95-99.
24. Whelan HT, Connelly JF, Hodgson BD, Barbeau L, Post AC, Bullard G, et al. NASA Light-emitting diode for the prevention of oral mucositis in pediatric bone marrow transplant patient. J Clin Laser Med Surg 2002;20:319-324.
25. Corti L, Chiarion-Sileni V, Aversa S, Ponzoni A, D'Arcais R, Pagnutti S, et al. Treatment of chemotherapy-induced oral mucositis with light emitting diode. Photomed Laser Surg 2006;24:207-213.
26. Mezadri TJ, Tomáz VA, Amaral VLL. Animals de laboratório: Cuidados na iniciation experimental. Florianópolis: Editora da UFSC; 2004.
27. Sonis ST, Tracey C, Shklar G, Jenson J, Florine D. An animal model for mucositis induced by cancer chemotherapy. Oral Surg Oral Med Oral Pathol 1990;69:437-443.
28. Sonis ST, Peterson RL, Edwards LJ, Lucey CA, Wang L, Mason L, et al. Defining mechanisms of action of interleukin-11 on the progression of radiation-induced oral mucositis in hamsters. Oral Oncol 2000;36:373-381.
29. Squier CA, Kremer MJ. Biology of oral mucosa and esophagus. J Natl Cancer Inst Monogr 2001;29:7-15.
30. Loury DJ, Embree JR, Steinberg DA, Sonis ST, Fiddes JC. Effect of local application of the antimicrobial peptide IB-367 on the incidence and severity of oral mucositis in hamsters. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1999;87:544-551.
31. Morvan FO, Baroukh B, Ledoux D, Caruelle JP, Barritault D, Godeau G, et al. An engineered biopolymer prevents mucositis induced by 5-fluorouracil in hamsters. Am J Pathol 2004;164:739-746.
32. Sonis ST, Lindquist L, Vugt AV, Stewart AA, Stam K, Qu GY, et al. Prevention of chemotherapy-induced ulcerative mucositis by transforming growth factor beta 3. Cancer Res 1994;54:1135-1138.
33. Sonis ST, O'Donnell KE, Popat R, Bragdon C, Phelan S, Cocks D, et al. The relationship between mucosal cyclooxygenase-2 (COX-2) expression and experimental radiationinduced mucositis. Oral Oncol 2004;40:170-176.
34. Clarke J, Edwards B, Srpek L, Regester G. Evaluation of bovine lactoferrin as a topical therapy for chemotherapy-induced mucositis in the golden Syrian hamster. Oral Oncol 1999;35:197-202.
35. Clarke J, Butler R, Howard G, Read L, Regester G. Exposure of oral mucosa to bioactive milk factors reduces severity of chemotherapy-induced mucositis in the hamsters. Oral Oncol 2002;38:478-485.
36. Lima V, Brito GAC, Cunha FQ, Rebouças CG, Falcão BAA, Augusto RF. Effects of the tumor necrosis factor-α pentoxifylline and thalidomide in short-term experimental oral mucositis in hamsters. Eur J Oral Sci 2005;113:210-217.
37. Leitão RFC, Ribeiro RA, Bellaguarda EAL, Macedo FDB, Silva LR, Oriá RB, et al. Role of nitric oxide on pathogenesis of 5-fuorouracil induced experimental oral mucositis in hamsters. Cancer Chemother Pharmacol 2007;59:603-612.
38. Sonis ST. The pathobiology of mucositis. Nat Rev Cancer 2004;4:277-284.
39. Migliorati C, Massumoto C, Eduardo FP, Muller KP, Carrieri T, Haypek P, et al. Low-energy laser therapy in oral mucositis. J Oral Laser Appl 2001;1:97-101.
40. Karu T. Photobiology of low-power laser effects. Health Phys 1989;56:691-704.
41. Sommer AP, Pinheiro ALB, Mester AR, Franke RP, Whelan HT. Biostimularoty window in low-intensity laser activation: Lasers, scanners, and NASA's light-emitting diode array system. J Clin Laser Med Surg 2001;19:29-33.
42. Sacono NT, Ferrari JCL, Abreu-e-Lima FCB. Use of red and infrared LED for the treatment chemotherapy-induced mucositis in hamsters. Braz Oral Res 2005;19:219-219.
43. McCarthy GM, Awde JD, Ghandi H, Vincent M, Kocha WI. Risk factors associated with mucositis in cancer patients receiving 5-fluorouracil. Oral Oncol 1998;34:484-490.
44. Lim W, Lee S, Kim I, Chung M, Kim M, Lim H, Park J, Kim O, Choi H. The anti-inflammatory mechanism of 635 nm light-emitting-diode irradiation compared with existing COX inhibitors. Lasers Surg Med 2007;39:614-621.
45. Brune K. Safety of anti-inflammatory treatment - New ways of thinking. Rheumatology 2004;43(Suppl 1):i16-i20.